Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.59 |
| ▸ | NAAA | Q02083 | 1/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.59 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL151961 | 1.00 | GPR84 (0.59) | GPR84NAAAFFAR1EPHX1TSHR | |
| SCHEMBL4133210 | 1.00 | GPR84 (0.59) | GPR84NAAAFFAR1EPHX1TSHR | |
| SCHEMBL8376969 | 1.00 | GPR84 (0.59) | GPR84NAAAFFAR1EPHX1TSHR | |
| SCHEMBL11922960 | 1.00 | GPR84 (0.59) | GPR84NAAAFFAR1EPHX1TSHR | |
| SCHEMBL6864319 | 1.00 | GPR84 (0.59) | GPR84NAAAFFAR1EPHX1TSHR | |
| SCHEMBL8375622 | 1.00 | GPR84 (0.59) | GPR84NAAAFFAR1EPHX1TSHR | |
| SCHEMBL17373195 | 1.00 | GPR84 (0.59) | GPR84NAAAFFAR1EPHX1TSHR | |
| SCHEMBL13002969 | 1.00 | GPR84 (0.59) | GPR84NAAAFFAR1EPHX1TSHR | |
| SCHEMBL8981942 | 1.00 | GPR84 (0.59) | GPR84NAAAFFAR1EPHX1TSHR | |
| SCHEMBL15129028 | 1.00 | GPR84 (0.59) | GPR84NAAAFFAR1EPHX1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8653117-B2 | Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof | LABORATOIRES EXPANSCIENCE (FR) | 2014-02-18 | — | — | US | disclosed |
| US-8653117-B2 | Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof | LABORATOIRES EXPANSCIENCE (FR) | 2014-02-18 | — | — | US | disclosed |
| US-8304453-B2 | Composition comprising at least one alkanolamide to inhibit migration of langerhans cells and uses therof | LABORATOIRES EXPANSCIENCE (FR) | 2012-11-06 | — | — | US | disclosed |
| US-8304453-B2 | Composition comprising at least one alkanolamide to inhibit migration of langerhans cells and uses therof | LABORATOIRES EXPANSCIENCE (FR) | 2012-11-06 | — | — | US | disclosed |
| US-20090137453-A1 | COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE TO INHIBIT MIGRATION OF LANGERHANS CELLS, AND USES THEREOF | MSIKA PHILIPPE | 2009-05-28 | — | — | US | disclosed |
| US-20090137453-A1 | COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE TO INHIBIT MIGRATION OF LANGERHANS CELLS, AND USES THEREOF | MSIKA PHILIPPE | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137453-A1 | COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE TO INHIBIT MIGRATION OF LANGERHANS CELLS, AND USES THEREOF | ARG1, MIF, ZAP70 | GPR84 654/4885NAAA 961/4885FFAR1 1409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.